OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions
- PMID: 30709963
- PMCID: PMC6675671
- DOI: 10.3899/jrheum.181071
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions
Abstract
Objective: The Outcome Measures in Rheumatology (OMERACT) Shared Decision Making (SDM) Working Group aims to determine the core outcome domain set for measuring the effectiveness of SDM interventions in rheumatology trials.
Methods: A white paper was developed to clarify the draft core domain set. It was then used to prepare for interviews to investigate reasons for lack of consensus on it and to suggest further improvements.
Results: OMERACT scientists/clinicians (n = 13) and patients (n = 10) suggested limiting the core domain set to outcome domains, removing process domains, and clarifying remaining domains.
Conclusion: A revised core domain set will undergo further consensus-building.
Keywords: OMERACT; OUTCOMES; RHEUMATIC DISEASES.
Conflict of interest statement
Figures
References
-
- Elwyn G, Tilburt J, Montori V. The ethical imperative for shared decision-making. Eur J Pers Cent Healthc 2013;1:129–31.
-
- Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960–77. - PubMed
-
- Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 2016;75:499–510. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources